SCHEMBL9052816

SCHEMBL9052816

COc1cc2c(N3CCc4ccc(Cl)cc43)ncnc2cc1O.COc1cc2ncnc(N3CCc4ccc(Cl)cc43)c2cc1OC

nearest known ligand 0.66

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.66
CSF1R P07333 1/20 0.64
RET P07949 2/20 0.61
KIF5B P33176 1/20 0.61
KDR P35968 1/20 0.61
KIT P10721 2/20 0.50
ACHE P22303 2/20 0.49
BACE1 P56817 2/20 0.49
PDGFRB P09619 7/20 0.48
PDGFRA P16234 4/20 0.48
PDE1B Q01064 1/20 0.47
PDE10A Q9Y233 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8647145 0.98 EGFR (0.62) EGFRCSF1RRETKIF5BKDR
SCHEMBL8649000 0.94 EGFR (0.73) EGFRCSF1RRETKIF5BKDR
SCHEMBL8649983 0.88 EGFR (0.64) EGFRCSF1RRETKIF5BKDR
SCHEMBL8650199 0.86 EGFR (0.49) EGFRCSF1RRETKIF5BKDR
SCHEMBL8648185 0.86 EGFR (0.62) EGFRCSF1RRETKIF5BKDR
SCHEMBL8645752 0.85 EGFR (0.62) EGFRCSF1RRETKIF5BKDR
SCHEMBL8645023 0.85 EGFR (0.73) EGFRCSF1RRETKIF5BKDR
Lithium SCHEMBL9114231 0.85 EGFR (0.59) EGFRCSF1RRETKIF5BKDR
Lithium Ion SCHEMBL9114215 0.85 EGFR (0.59) EGFRCSF1RRETKIF5BKDR
SCHEMBL9114206 0.85 EGFR (0.59) EGFRCSF1RRETKIF5BKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0746554-A1 4-HETEROCYCLYL-SUBSTITUTED QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS ANTI-CANCER AGENTS PFIZER INC. (US) 1996-12-11 EP disclosed
WO-1995023141-A1 4-HETEROCYCLYL-SUBSTITUTED QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS ANTI-CANCER AGENTS PFIZER INC. (US) 1995-08-31 WO disclosed